JP2020535128A5 - - Google Patents

Info

Publication number

JP2020535128A5

JP2020535128A5 JP2020515969A JP2020515969A JP2020535128A5 JP 2020535128 A5 JP2020535128 A5 JP 2020535128A5 JP 2020515969 A JP2020515969 A JP 2020515969A JP 2020515969 A JP2020515969 A JP 2020515969A JP 2020535128 A5 JP2020535128 A5 JP 2020535128A5

Authority

JP

Japan

Prior art keywords

car

item

composition

ligand

ligand conjugate

Prior art date

2018-09-19

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 239000000203 mixture Substances 0.000 claims description 89
• 239000003446 ligand Substances 0.000 claims description 88
• 238000000034 method Methods 0.000 claims description 40
• 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 35
• 230000002163 immunogen Effects 0.000 claims description 35
• 239000000427 antigen Substances 0.000 claims description 30
• 102000036639 antigens Human genes 0.000 claims description 30
• 108091007433 antigens Proteins 0.000 claims description 30
• 206010028980 Neoplasm Diseases 0.000 claims description 28
• 150000002632 lipids Chemical class 0.000 claims description 26
• 210000004027 cell Anatomy 0.000 claims description 24
• 239000002671 adjuvant Substances 0.000 claims description 16
• 108091034117 Oligonucleotide Proteins 0.000 claims description 15
• 102000004169 proteins and genes Human genes 0.000 claims description 15
• 108090000623 proteins and genes Proteins 0.000 claims description 15
• 238000011357 CAR T-cell therapy Methods 0.000 claims description 13
• 125000001183 hydrocarbyl group Chemical group 0.000 claims description 11
• 201000011510 cancer Diseases 0.000 claims description 10
• 239000003937 drug carrier Substances 0.000 claims description 10
• 239000002202 Polyethylene glycol Substances 0.000 claims description 8
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims description 8
• 125000003827 glycol group Chemical group 0.000 claims description 8
• 230000003308 immunostimulating effect Effects 0.000 claims description 8
• 229920001223 polyethylene glycol Polymers 0.000 claims description 8
• 239000012634 fragment Substances 0.000 claims description 6
• 230000001965 increasing effect Effects 0.000 claims description 6
• 230000035755 proliferation Effects 0.000 claims description 6
• 230000003213 activating effect Effects 0.000 claims description 5
• 125000002252 acyl group Chemical group 0.000 claims description 5
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
• LVNGJLRDBYCPGB-LDLOPFEMSA-N (R)-1,2-distearoylphosphatidylethanolamine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCCC LVNGJLRDBYCPGB-LDLOPFEMSA-N 0.000 claims description 4
• 108010004729 Phycoerythrin Proteins 0.000 claims description 4
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
• 230000028993 immune response Effects 0.000 claims description 4
• 230000004962 physiological condition Effects 0.000 claims description 4
• UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 claims description 2
• 102000009027 Albumins Human genes 0.000 claims description 2
• 108010088751 Albumins Proteins 0.000 claims description 2
• 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 2
• 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 2
• 108010015776 Glucose oxidase Proteins 0.000 claims description 2
• 239000004366 Glucose oxidase Substances 0.000 claims description 2
• 108010043121 Green Fluorescent Proteins Proteins 0.000 claims description 2
• 102000004144 Green Fluorescent Proteins Human genes 0.000 claims description 2
• 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 2
• 108700020482 Maltose-Binding protein Proteins 0.000 claims description 2
• 108010090804 Streptavidin Proteins 0.000 claims description 2
• 102000002689 Toll-like receptor Human genes 0.000 claims description 2
• 108020000411 Toll-like receptor Proteins 0.000 claims description 2
• 241000700605 Viruses Species 0.000 claims description 2
• UYRDHEJRPVSJFM-VSWVFQEASA-N [(1s,3r)-3-hydroxy-4-[(3e,5e,7e,9e,11z)-11-[4-[(e)-2-[(1r,3s,6s)-3-hydroxy-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-6-yl]ethenyl]-5-oxofuran-2-ylidene]-3,10-dimethylundeca-1,3,5,7,9-pentaenylidene]-3,5,5-trimethylcyclohexyl] acetate Chemical compound C[C@@]1(O)C[C@@H](OC(=O)C)CC(C)(C)C1=C=C\C(C)=C\C=C\C=C\C=C(/C)\C=C/1C=C(\C=C\[C@]23[C@@](O2)(C)C[C@@H](O)CC3(C)C)C(=O)O\1 UYRDHEJRPVSJFM-VSWVFQEASA-N 0.000 claims description 2
• 150000001413 amino acids Chemical class 0.000 claims description 2
• 230000006023 anti-tumor response Effects 0.000 claims description 2
• 229960002685 biotin Drugs 0.000 claims description 2
• 235000020958 biotin Nutrition 0.000 claims description 2
• 239000011616 biotin Substances 0.000 claims description 2
• 210000000170 cell membrane Anatomy 0.000 claims description 2
• 229930002875 chlorophyll Natural products 0.000 claims description 2
• 235000019804 chlorophyll Nutrition 0.000 claims description 2
• ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 claims description 2
• 201000010099 disease Diseases 0.000 claims description 2
• 229940116332 glucose oxidase Drugs 0.000 claims description 2
• 235000019420 glucose oxidase Nutrition 0.000 claims description 2
• 150000004676 glycans Chemical class 0.000 claims description 2
• 239000005090 green fluorescent protein Substances 0.000 claims description 2
• 229920001477 hydrophilic polymer Polymers 0.000 claims description 2
• 230000001939 inductive effect Effects 0.000 claims description 2
• 230000026792 palmitoylation Effects 0.000 claims description 2
• UTIQDNPUHSAVDN-UHFFFAOYSA-N peridinin Natural products CC(=O)OC1CC(C)(C)C(=C=CC(=CC=CC=CC=C2/OC(=O)C(=C2)C=CC34OC3(C)CC(O)CC4(C)C)C)C(C)(O)C1 UTIQDNPUHSAVDN-UHFFFAOYSA-N 0.000 claims description 2
• 229920001282 polysaccharide Polymers 0.000 claims description 2
• 239000005017 polysaccharide Substances 0.000 claims description 2
• 230000004936 stimulating effect Effects 0.000 claims description 2
• 230000004614 tumor growth Effects 0.000 claims description 2
• 230000003612 virological effect Effects 0.000 claims description 2
• 230000000139 costimulatory effect Effects 0.000 claims 1
• OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 claims 1
• 239000000126 substance Substances 0.000 claims 1
• 239000003814 drug Substances 0.000 description 8
• 238000009472 formulation Methods 0.000 description 7
• 210000001165 lymph node Anatomy 0.000 description 6
• 210000001519 tissue Anatomy 0.000 description 5
• 208000036142 Viral infection Diseases 0.000 description 4
• 230000009385 viral infection Effects 0.000 description 4
• 210000001744 T-lymphocyte Anatomy 0.000 description 3
• 150000001875 compounds Chemical class 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• 241000725303 Human immunodeficiency virus Species 0.000 description 2
• 210000000612 antigen-presenting cell Anatomy 0.000 description 2
• 230000002146 bilateral effect Effects 0.000 description 2
• PKFDLKSEZWEFGL-MHARETSRSA-N c-di-GMP Chemical group C([C@H]1O2)OP(O)(=O)O[C@H]3[C@@H](O)[C@H](N4C5=C(C(NC(N)=N5)=O)N=C4)O[C@@H]3COP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 PKFDLKSEZWEFGL-MHARETSRSA-N 0.000 description 2
• 210000004443 dendritic cell Anatomy 0.000 description 2
• 230000004941 influx Effects 0.000 description 2
• 230000021633 leukocyte mediated immunity Effects 0.000 description 2
• 108091007741 Chimeric antigen receptor T cells Proteins 0.000 description 1
• 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 1
• 102100022338 Integrin alpha-M Human genes 0.000 description 1
• 230000005975 antitumor immune response Effects 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 208000035475 disorder Diseases 0.000 description 1
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 238000004519 manufacturing process Methods 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 230000009635 nitrosylation Effects 0.000 description 1
• 102000007863 pattern recognition receptors Human genes 0.000 description 1
• 108010089193 pattern recognition receptors Proteins 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• 229940127557 pharmaceutical product Drugs 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 210000004881 tumor cell Anatomy 0.000 description 1
• 229960005486 vaccine Drugs 0.000 description 1